Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
11/2007
11/21/2007EP1431284B1 Diaryl sulfide derivative, addition salt thereof, and immunosuppressant
11/21/2007EP1427824B1 Use of microbiology non-viral substances for treating acne
11/21/2007EP1385498B1 Fatty acids as neutrophil survival and activation factors.
11/21/2007EP1363594B1 Cosmetic formulations containing flavonoid derivatives
11/21/2007EP1301500B1 Nitrosated and nitrosylated taxanes, compositions and methods of use
11/21/2007EP0842196B1 Cell adhesion inhibitors
11/21/2007CN200977288Y Exterior-applied plaster for treating subcutaneous and lipoma
11/21/2007CN101076348A Compositions and methods for inducing melanogenesis in a subject
11/21/2007CN101076336A Novel curcumin analogues and uses thereof
11/21/2007CN101076326A Method of using adapalene in acne maintenance therapy
11/21/2007CN101076316A Composition and method for accelerating fibulin-5 production and/or enhancing fibulin-5 activity
11/21/2007CN101073655A Chinese medicine for treating pityriasis roasea, psoriasis and drug eruption
11/21/2007CN101073654A Method for treating wet-resisting eczema
11/21/2007CN101073650A Method for treating blood-heat eczema
11/21/2007CN101073649A Method for damp-heat eczema
11/21/2007CN101073642A Chinese-medicinal formula for treating various skin diseases and its production
11/21/2007CN101073641A Chinese-medicinal powder for treating trauma
11/21/2007CN101073638A Treatment of cystic acne and cicatrix
11/21/2007CN101073637A Method for treating blood-dryness type eczema
11/21/2007CN101073630A Externally-applied cream for treating various diseases
11/21/2007CN101073629A Externally-applied health-care products for relieving itch and its production
11/21/2007CN101073624A Chinese-medicinal preparation with stink-dispelling and itching-relieving functions for beriberi
11/21/2007CN101073612A Externally-applied health-care product for relieving burn and scald and its production
11/21/2007CN101073579A Medicine for treating skin diseases and its production
11/21/2007CN101073575A Capsule for treating acne
11/21/2007CN101073548A Antidotic spot-dispelling face mask
11/21/2007CN101073545A Pox-removing face mask
11/21/2007CN101073544A Spot-relieving face mask
11/21/2007CN101073541A Spot-eliminating cream
11/21/2007CN101073537A Fine emulsion of oil in water
11/21/2007CN101073355A Beauty health-care tea
11/21/2007CN101073340A Rose beauty sour milk
11/21/2007CN100349887C Substituted 4-aryl-4H-pyrrolo[2,3-H]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/21/2007CN100349606C Drug tincture for treating flat wart, and preparation method
11/21/2007CN100349604C Medicine for treating skin scald and burn and preparation method thereof
11/21/2007CN100349566C Medicine for treating eczema and its preparing process
11/21/2007CN100349556C Use of autologous dermal fibroblasts for repair of skin and soft tissue defects
11/20/2007US7297818 Adamantane derivatives
11/20/2007US7297792 Pyrazolopyridines and pyrazolopyridazines as antidiabetics
11/20/2007US7297715 PPAR alpha selective compounds for the treatment of dyslipidemia and other lipid disorders
11/20/2007US7297698 e.g. (2R,5S)-4-(3-chloro-4-cyanophenyl)-N-(2-cyclopropylpyrimidin-5-yl)-2,5-dimethylpiperazine-1-carboxamide; antiandrogenic agent
11/20/2007US7297692 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them
11/20/2007US7297681 For use in therapy of growth metabolic disorders
11/20/2007US7297677 Method of improving the skin barrier function of a pet
11/20/2007US7297523 Human elongase genes and uses thereof
11/20/2007CA2341410C Hydrogel compositions for the controlled release administration of growth factors
11/20/2007CA2268600C Topical dmso treatment for palmar-plantar erythrodysesthesia
11/20/2007CA2262409C Modified tie-2-receptor ligands
11/20/2007CA2204745C Antiparasitic composition for the treatment and protection of pets
11/20/2007CA2140382C Vitamin d compounds and method of preparing these compounds
11/15/2007WO2007130075A1 Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
11/15/2007WO2007129952A1 Novel peptide derivatives useful as antimicrobial agents for treating wounds
11/15/2007WO2007129743A1 Anti-inflammatory composition
11/15/2007WO2007129729A1 Process for production of fish-derived ceramide, and ceramide-containing composition
11/15/2007WO2007129674A1 Fermented product composition, cosmetic composition and method of producing the same
11/15/2007WO2007129618A1 Inhibitor of neutrophil activation/migration factor and use thereof
11/15/2007WO2007129473A1 Bicyclic aryl derivative
11/15/2007WO2007129133A1 Ointment or cream for the topical treatment of psoriasis
11/15/2007WO2007128725A1 6h-benzofuro[3,2-c] [1]benzopyran and [2] benzopyrano [4,3-b] [1]benzopyran derivatives and wood extracts of these compounds as aryl hydrocarbon receptor (ahr) antagonists for the prevention of uv-b induced skin damage
11/15/2007WO2007128723A1 Ah receptor antagonists
11/15/2007WO2007128564A2 Use of a compound with rankl activity
11/15/2007WO2007109355A3 6,7,8, 9 -tetrahydro- 5h- pyrimido [4, 5-d] azepin-4-yl] -amine derivatives as modulators of trpvl for the treatment of pain
11/15/2007WO2007022616A8 Hybrid ultrafast laser surgery and growth factor stimulation for ultra-precision surgery with healing
11/15/2007US20070265449 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
11/15/2007US20070265323 Compounds for the treatment of metabolic disorders
11/15/2007US20070265322 Compounds for the treatment of metabolic disorders
11/15/2007US20070265320 (2S,4S)-1-[[(4-carbamoylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile, for treating type II diabetes; increase glucagon-like peptide activity
11/15/2007US20070265299 Compounds for the treatment of inflammatory disorders
11/15/2007US20070265286 Quinazoline derivatives as VEGF inhibitors
11/15/2007US20070265280 Methods of using sodium channel blockers
11/15/2007US20070265279 Use of mGluR5 antagonists for the treatment of pruritic conditions
11/15/2007US20070265274 4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide for treating mutated-ret kinase associated diseases
11/15/2007US20070265263 Heterocyclic inhibitors of ERK2 and uses thereof
11/15/2007US20070265260 Quinazoline derivatives
11/15/2007US20070265250 Imidazole compounds
11/15/2007US20070265239 Topically applicable anti-inflammatory O/W emulsions comprising pro-penetrating glycols
11/15/2007US20070265228 decreases expression of a Type I collage gene in a tissue to induce a reduction in accumulation of collagen and thereby improves tissue fibrosis
11/15/2007US20070265210 Administration of C-glycoside compounds for protecting and/or activating gammadeltaT lymphocytes
11/15/2007US20070265201 Inhibitors of inflammatory cytokine transcription derived from hcmv protein ie2
11/15/2007US20070264344 Topically applicable anti-inflammatory O/W emulsions comprising pro-penetrating glycols
11/15/2007US20070264321 Method of treating skin wounds with vectors encoding hepatocyte growth factor
11/15/2007US20070264290 Pharmaceutical and/or Cosmetic Care Product, Such as a Mask
11/15/2007US20070264288 Method for Dermatological Treatment Using Chromophores
11/15/2007US20070264247 Use of Human Lysozyme in Preparation of Medicine for Treating Acne
11/15/2007US20070264230 Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligands
11/15/2007US20070264212 Skin Lightening Method
11/15/2007US20070264211 Composition Comprising Sodium Silicate for Use in the Treatment of Dry Skin Conditions
11/15/2007US20070264205 reducing the formation of cellulite in skin by topically applying to the skin a composition having a cosmetically acceptable vehicle and an effective amount of carnitine creatinate
11/15/2007DE102006021198A1 Concentrated aqueous solution of sodium chloride in combination with concentrated aqueous solution of sodium chloride with UV-A light or UV-B light for dermal application against skin disease (pigment disorder), preferably vitiligo
11/15/2007CA2651201A1 Use of a compound with rankl activity
11/15/2007CA2618646A1 Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
11/14/2007EP1854793A1 NOVEL AMINOPYRIDINE COMPOUND WITH Syk INHIBITORY ACTIVITY
11/14/2007EP1854787A1 Novel cyclic compound having quinolylalkylthio group
11/14/2007EP1854480A2 Treatment of LFA-1 associated disorders with increasing doses of LFA-1 antagonist
11/14/2007EP1854469A1 Fermentation composition having immunomodulating effect
11/14/2007EP1854466A1 Pharmaceutical composition comprising a combination of calcitriol and clobetasol propionate
11/14/2007EP1854458A1 Use of a compound with RANKL activity
11/14/2007EP1853570A2 Hsp90-inhibiting triazole derivatives
11/14/2007EP1853352A2 Use of 3-sulfanylpropanamide derivatives for stimulating hair and eyelash growth and/or for stopping the loss and/or limiting the depigmentation thereof
11/14/2007EP1853242A2 Small molecule inhibitors of stat3 and the uses thereof
1 ... 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 ... 1065